Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP295580.RAf9Ff8WlLAGYSWpSOD6LC_h9D3efjfVx_CYmO39hNJBE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP295580.RAf9Ff8WlLAGYSWpSOD6LC_h9D3efjfVx_CYmO39hNJBE130_assertion type Assertion NP295580.RAf9Ff8WlLAGYSWpSOD6LC_h9D3efjfVx_CYmO39hNJBE130_head.
- NP295580.RAf9Ff8WlLAGYSWpSOD6LC_h9D3efjfVx_CYmO39hNJBE130_assertion description "[Immunohistochemistry for NUDT2 was examined by invasive ductal carcinoma (IDC: n = 145) and pure ductal carcinoma in situ (DCIS: n = 82), and NUDT2 mRNA was examined by real-time PCR in 9 DCIS, 19 IDC and 6 non-neoplastic breast tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP295580.RAf9Ff8WlLAGYSWpSOD6LC_h9D3efjfVx_CYmO39hNJBE130_provenance.
- NP295580.RAf9Ff8WlLAGYSWpSOD6LC_h9D3efjfVx_CYmO39hNJBE130_assertion evidence source_evidence_literature NP295580.RAf9Ff8WlLAGYSWpSOD6LC_h9D3efjfVx_CYmO39hNJBE130_provenance.
- NP295580.RAf9Ff8WlLAGYSWpSOD6LC_h9D3efjfVx_CYmO39hNJBE130_assertion SIO_000772 20533549 NP295580.RAf9Ff8WlLAGYSWpSOD6LC_h9D3efjfVx_CYmO39hNJBE130_provenance.
- NP295580.RAf9Ff8WlLAGYSWpSOD6LC_h9D3efjfVx_CYmO39hNJBE130_assertion wasDerivedFrom befree-20140225 NP295580.RAf9Ff8WlLAGYSWpSOD6LC_h9D3efjfVx_CYmO39hNJBE130_provenance.
- NP295580.RAf9Ff8WlLAGYSWpSOD6LC_h9D3efjfVx_CYmO39hNJBE130_assertion wasGeneratedBy ECO_0000203 NP295580.RAf9Ff8WlLAGYSWpSOD6LC_h9D3efjfVx_CYmO39hNJBE130_provenance.